Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Pharmacognosy CommunicationsNOW IN
    Article

    Inhalation Absorption Prediction (IAP) Model for Predicting Medicinal Cannabis Phytochemical Pharmacokinetics

    Kimber Wise1,2, Harsharn Gill1, Jamie Selby-Pham2★★ Corresponding author

    1. 1School of Science, RMIT University, Bundoora VIC 3083, AUSTRALIA.
    2. 2Nutrifield, Sunshine West VIC 3020, AUSTRALIA.

    CORRESPONDENCE

    Jamie Selby-Pham

    Nutrifield, Sunshine West VIC 3020, AUSTRALIA.

    Jamies@nutrifield.com.au

    Volume 9, Issue 3 · pp. 85–90 · PUBLISHED · DOI: 10.5530/pc.2019.3.18

    View on Pharmacogn. Commn. original site ↗

    ABSTRACT

    Introduction: The medicinal benefits from inhalation of Cannabis sativa phytochemicals have been extensively reported. Whilst in-silico models are available for prediction of phytochemical pharmacokinetics post-ingestion, no models are available to accurately predict inhalation pharmacokinetics. Therefore, the aim of this study was to explore the relationship between phytochemical physicochemical properties and inhalation pharmacokinetics and to develop an in-silico model for predicting the time of maximal compound concentration in plasma (Tmax) and compound elimination half-life (T½), following inhalation. Methods: A training set of compound pharmacokinetic data was collated from previous publications and compared to physicochemical parameters using regression analyses. Physicochemical parameters that correlated with Tmax and T½ were combined to develop a statistical model, which constructs functional fingerprints predicting compound concentrations in plasma post inhalation. Predicted functional fingerprints for three cannabis bioactive compounds were constructed and biomatched against previously reported physiological effects. Results: Inhalation Tmax was predicted (r2 = 0.84) by compound volume (Vol), topological surface area (TPSA) and molecular weight (MW), whilst T½ was predicted (r2 = 0.87) by molecular weight, volume and number of rotatable bonds (nrot). The resulting inhalation absorption prediction (IAP) model was achieved by combining Tmax and T½ predictions. The IAP model was applied to cannabis metabolites which accurately predicted decay functions in-vivo and biomatching with associated physiological effects. Conclusion: The IAP model was applied successfully to cannabis phytochemicals to explore the pharmacokinetics underpinning their medicinal effects. This study demonstrates the utility of the IAP model and highlights its applicability during the investigation of medicinal plants and their modes of action.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Wise, K., Gill, H., & Selby-Pham, J. (). Inhalation Absorption Prediction (IAP) Model for Predicting Medicinal Cannabis Phytochemical Pharmacokinetics. Pharmacognosy Communications, 9(3), 85–90. https://doi.org/10.5530/pc.2019.3.18